Form S-1/A AIM ImmunoTech Inc For: 29 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AIM ImmunoTech Inc (AIM)
AIM ImmunoTech Inc stock price live, this page displays NYSE AIM stock exchange data. View the AIM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AIM ImmunoTech Inc real time stock price chart below.
What Is the AIM ImmunoTech Inc Stock Price Today?
The AIM ImmunoTech Inc stock price today is 0.97.
What Is the Stock Symbol for AIM ImmunoTech Inc?
The stock symbol for AIM ImmunoTech Inc is "AIM."
What Stock Exchange Does AIM ImmunoTech Inc Trade On?
AIM ImmunoTech Inc is listed and trades on the NYSE stock exchange.
Is AIM ImmunoTech Inc a Good Stock to Buy?
Determining whether AIM ImmunoTech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AIM quote. (ISIN: US00901B3033)
What Is the AIM ImmunoTech Inc Stock Price Today?
The AIM ImmunoTech Inc stock price today is 0.97.
What Is the Stock Symbol for AIM ImmunoTech Inc?
The stock symbol for AIM ImmunoTech Inc is "AIM."
What Stock Exchange Does AIM ImmunoTech Inc Trade On?
AIM ImmunoTech Inc is listed and trades on the NYSE stock exchange.
Is AIM ImmunoTech Inc a Good Stock to Buy?
Determining whether AIM ImmunoTech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AIM quote. (ISIN: US00901B3033)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.77
1.10
52 wk Range
0.77
35.96
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.771.10
52 wk Range
0.7735.96
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AIM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
13.99
Upside
+1,341.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Form S-1/A AIM ImmunoTech Inc For: 23 January
- Investing.com
- Form 8K AIM ImmunoTech Inc For: 29 October
- Investing.com
- Form S-1/A AIM ImmunoTech Inc For: 29 January
- Investing.com
- Form S-1/A AIM ImmunoTech Inc For: 23 January
- Investing.com
- Form 8K AIM ImmunoTech Inc For: 20 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
AIM ImmunoTech Inc Company Profile
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Compare AIM to Peers and Sector
Metrics to compare | AIM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAIMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −2.6x | −0.5x | |
PEG Ratio | 0.00 | −0.05 | 0.00 | |
Price/Book | −0.5x | 2.6x | 2.6x | |
Price / LTM Sales | 24.7x | 163.7x | 3.3x | |
Upside (Analyst Target) | - | 91.5% | 45.0% | |
Fair Value Upside | Unlock | −3.2% | 5.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.99
(+1,341.86% Upside)
Earnings
Latest Release
Nov 17, 2025
EPS / Forecast
-1.57 / -8.00
Revenue / Forecast
26.00K / --
People Also Watch
FAQ
What Is the AIM ImmunoTech (AIM) Stock Price Today?
The AIM ImmunoTech stock price today is 0.97
What Stock Exchange Does AIM ImmunoTech Trade On?
AIM ImmunoTech is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for AIM ImmunoTech?
The stock symbol for AIM ImmunoTech is "AIM."
What Is the AIM ImmunoTech Market Cap?
As of today, AIM ImmunoTech market cap is 2.77M.
What Is AIM ImmunoTech's Earnings Per Share (TTM)?
The AIM ImmunoTech EPS (TTM) is -14.89.
From a Technical Analysis Perspective, Is AIM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has AIM ImmunoTech Stock Split?
AIM ImmunoTech has split 2 times.
How Many Employees Does AIM ImmunoTech Have?
AIM ImmunoTech has 22 employees.
What is the current trading status of AIM ImmunoTech (AIM)?
As of Feb 10, 2026, AIM ImmunoTech (AIM) is trading at a price of 0.97, with a previous close of 0.97. The stock has fluctuated within a day range of 0.77 to 1.10, while its 52-week range spans from 0.80 to 35.96.
What Is AIM ImmunoTech (AIM) Price Target According to Analysts?
The average 12-month price target for AIM ImmunoTech is USD13.99, with a high estimate of USD21.97802 and a low estimate of USD5.99401. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,341.86% Upside potential.
What Is the AIM Premarket Price?
AIM's last pre-market stock price is 0.98. The pre-market share volume is 870.00, and the stock has decreased by 0.01, or 1.03%.
What Is the AIM After Hours Price?
AIM's last after hours stock price is 1.00, the stock has decreased by 0.03, or 3.09%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.